This is filed to report the access site aneurysm, fistula, hematoma, and stenosis.It was reported that this was a mitraclip procedure to treat grade 3 mixed etiology mitral regurgitation (mr).On (b)(6) 2018 one mitraclip was implanted through the steerable guide catheter via the right groin access site, reducing mr grade to 1.On (b)(6) 2018 the patient had right groin pain.Duplex sonography found an aneurysm spurium arterio-venous fistula, hematoma, and stenosis of the femoral artery.Compression and compression bandages were performed for 24 hours; medication was administered, but the condition persisted.Surgical intervention for the condition was performed on (b)(6) 2018.No additional information was provided.
|
Internal file number: (b)(4).Two steerable guide catheters (sgc) were used.Since it could not be confirmed which of these may have contributed to the reported patient effects, the lot history record review is provided for both lots.The results are as follows: lot 80621u255: manufacturing date: 21-june-2018, expiration date: 21-june-2019.Lot 80815u108: manufacturing date: 15-august-2018, expiration date: 15-august-2019.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issues to the reported lot that would have contributed to this event.Review of the complaint history revealed no evidence of a lot-specific product quality issue.The reported patient effects of aneurysm, fistula, hematoma, pain, stenosis and surgery are listed in the mitraclip system instructions for use, as known possible complications associated with mitraclip procedures.The reported patient effects appear to be related to patient morphology/pathology and/or user technique/procedural conditions.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|